Solactive Global Health Services & Technology EMEA:
In the ordinary adjustment, the following composition will be implemented effective open 16th October 2025:
| ALCON INC |
| ALK-ABELLO A/S |
| ASTRAZENECA PLC |
| BIOMERIEUX |
| COLOPLAST AS CLASS B |
| DEMANT A/S |
| DIASORIN SPA |
| DR SULAIMAN AL HABIB MEDICAL SERVICES GROUP CO |
| ESSILORLUXOTTICA |
| FRESENIUS MEDICAL CARE AG & CO KGAA |
| FRESENIUS SE & CO KGAA |
| GSK PLC |
| HALEON PLC |
| HIKMA PHARMACEUTICALS PLC |
| INTERNATIONAL HOLDINGS CO PJSC |
| IPSEN SA |
| KONINKLIJKE PHILIPS NV |
| LABORATORIOS FARMACEUTICOS R |
| LONZA GROUP AG |
| MERCK KGAA |
| MLP SAGLIK HIZMETLERI AS |
| MOUWASAT MEDICAL |
| NOVARTIS AG |
| ORION OYJ CLASS B |
| RECORDATI SPA |
| RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO RT |
| ROCHE HOLDING AG |
| SANDOZ GROUP AG |
| SANOFI SA |
| SIEGFRIED HOLDING AG-REG |
| SIEMENS HEALTHINEERS AG |
| SONOVA HOLDING AG |
| SPECIALIZED MEDICAL ORD |
| STRAUMANN HOLDING AG |
| SWEDISH ORPHAN BIOVITRUM AB |
/fit-in/580x348/filters:format(webp)/english-betterindia/media/media_files/2026/08/04/5-2026-08-04-18-31-45.png)
